Three-dimensional echocardiography-derived right ventricular forward stroke volume to end-systolic volume index in tricuspid valve transcatheter edge-to-edge repair
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Abstract Background The ratio of right ventricular (RV) forward stroke volume (SV) to end-systolic volume (SV/RVESV), derived from three-dimensional (3D) echocardiography, has emerged as a noninvasive surrogate of RV-pulmonary artery (PA) coupling and is prognostically relevant in conservatively managed tricuspid regurgitation (TR). However, its role in patients undergoing tricuspid valve transcatheter edge-to-edge repair (T-TEER) remains unknown. Purpose To evaluate the prognostic value of SV/RVESV in patients undergoing T-TEER for severe TR. Methods This single-center retrospective study included consecutive patients undergoing T-TEER (2020–2023) with complete 3D RV volumetric data at baseline and discharge. The primary endpoint was 2-year survival. Results Seventy-five patients (median age 81 years; 65% female; 72% NYHA III/IV) had a median baseline SV/RVESV of 0.422 (0.353–0.521), increasing to 0.478 (0.359–0.592) at discharge (P=0.034). A baseline SV/RVESV >0.395 (High) was associated with superior 2-year survival compared with ≤0.395 (Low) (90.4% [95%CI: 80.4–100%] vs. 68.3% [95%CI: 51.8–90.2%]; P=0.021). Patients with low SV/RVESV had larger RV volumes, reduced RV function, and more advanced TR. Acute increases in SV/RVESV were confined to patients with residual TR ≤II, whereas no significant changes occurred in those with residual TR >II. Residual TR ≤II rates were similar between groups. Conclusion In patients undergoing T-TEER, baseline RV forward SV/RVESV was strongly associated with long-term survival. High SV/RVESV patients had less advanced RV remodeling, underscoring its potential for preprocedural risk stratification and timely intervention.
Fields of Study & Subjects
Cardiac Valve Diseases and Treatments
Cardiovascular Function and Risk Factors
Congenital Heart Disease Studies
Publication details
- Journal / source
- European Heart Journal Supplements
- Volume
- 28
- Issue
- Supplement_3
- Publication date
- 1 March 2026
- Language
- EN